North America Cardiac Leads Market Size, Share & Trends Analysis Report By Leads (Pacing Leads, Defibrillator Leads), By End Use (Hospitals, Ambulatory Surgery Centers), By Country (U.S., Canada, Mexico), And Segment Forecasts, 2025

The North America cardiac leads market size was estimated at USD 1.82 billion in 2024 and is projected to reach USD 2.52 billion by 2033, growing at a CAGR of 3.70% from 2025 to 2033. The rising prevalence of cardiovascular diseases (CVDs) in the U.S., including heart failure and arrhythmias, is being driven by multiple factors, notably sedentary lifestyles, obesity, and associated comorbidities.

According to the America Heart Association, in January 2024, the U.S. reported 931,578 deaths linked to cardiovascular disease, nearly 3,000 higher than the previous year, with the age-adjusted death rate climbing to 233.3 per 100,000 people, reflecting a 4.0% increase. This escalating disease load is contributing to a higher number of patients requiring device-based cardiac interventions, thereby strengthening demand for pacing leads and defibrillator leads essential for effective rhythm management.

Atrial fibrillation continues to be widely underdiagnosed in the U.S., often progressing silently until symptoms become clinically significant. According to the American Medical Association article published in February 2025, more than 5 million American adults are estimated to be living with AFib, and this number is expected to exceed 12 million by 2030, reflecting a rapidly growing arrhythmia burden across the country. While the patient population expands, hospitals and electrophysiology centers are seeing elevated demand for device-based rhythm stabilization, including pacemakers, conduction-system pacing solutions, and implantable defibrillators. Since these systems rely on high-quality cardiac leads to ensure accurate sensing and consistent electrical therapy, the increasing prevalence of AFib is directly strengthening the need for advanced pacing and defibrillator lead technologies throughout the U.S. and broader North America cardiac leads industry.

North America Cardiac Leads Market Report Segmentation

This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends in each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the North America cardiac leads market report based on lead, end use, and region:

Leads Outlook (Volume in '000 Units; Revenue in USD Million, 2021 - 2033)
Pacing Leads
- Standard RV/LV Leads
- Conduction System Pacing (CSP) / LBBAP Leads
Defibrillator Leads
- Traditional Leads
- LV Leads
End Use Outlook (Volume in '000 Units; Revenue in USD Million, 2021 - 2033)
Hospitals
Ambulatory Surgery Centers
Others
Country Outlook (Volume in '000 Units; Revenue in USD Million, 2021 - 2033)
U.S.
Canada
Mexico

Product Code: GVR-4-68040-819-5

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Segment scope
- 1.1.2. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
1.4. Information or Data Analysis
- 1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources

Chapter 2. North America Cardiac Leads Market: Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Leads Outlook
- 2.2.2. End Use Outlook
2.3. Competitive Insights

Chapter 3. North America Cardiac Leads Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
3.3. North America Cardiac Leads: Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTLE Analysis
3.4. Technology Trends
- 3.4.1. Cardiac Resynchronization Therapy (CRT) - CRT-D, CRT-P
- 3.4.2. Implantable Defibrillators
- 3.4.3. Pacing Devices (Pacemakers)
- 3.4.4. Leads (Pacing and Defibrillator Leads)
3.5. Competitive Factors and Strategies
- 3.5.1. Product Improvements & Innovations
- 3.5.2. Emerging Technologies
3.6. Market Developments and Key Clinical Trials In The CRM Market
- 3.6.1. Key Clinical Trials in the Cardiac Leads Market

Chapter 4. North America Cardiac Leads Market Segment Analysis, By Leads 2021 - 2033 (Revenue in USD Million; Unit Volume in '000 Units; Average Selling Price [USD per Unit])

4.1. Definition and Scope
4.2. Cardiac Leads Market Share Analysis, 2024 & 2033
4.3. Segment Dashboard
4.4. North America Cardiac Leads Market By Leads Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2021 To 2033, For the Following
4.6. Cardiac Leads Market Estimates and Forecasts 2021 To 2033 (USD Million)
4.7. Cardiac Leads Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
4.8. Average Selling Price Estimates & Forecast 2021 to 2033
- 4.8.1. Pacing Leads
  - 4.8.1.1. Pacing Cardiac Leads Market Estimates and Forecasts 2021 To 2033 (USD Million)
  - 4.8.1.2. Pacing Cardiac Leads Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  - 4.8.1.3. Average Selling Price Estimates & Forecast 2021 to 2033
    - 4.8.1.3.1. Standard RV/LV Leads
      - 4.8.1.3.1.1. Standard RV/LV Cardiac Leads Market Estimates and Forecasts 2021 To 2033 (USD Million)
      - 4.8.1.3.1.2. Standard RV/LV Cardiac Leads Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      - 4.8.1.3.1.3. Average Selling Price Estimates & Forecast 2021 to 2033
    - 4.8.1.3.2. Conduction System Pacing (CSP) / LBBAP Leads
      - 4.8.1.3.2.1. Conduction System Pacing (CSP) / LBBAP Cardiac Leads Market Estimates and Forecasts 2021 To 2033 (USD Million)
      - 4.8.1.3.2.2. Conduction System Pacing (CSP) / LBBAP Cardiac Leads Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      - 4.8.1.3.2.3. Average Selling Price Estimates & Forecast 2021 to 2033
- 4.8.2. Defibrillator Leads
  - 4.8.2.1. Defibrillator Cardiac Leads Market Estimates and Forecasts 2021 To 2033 (USD Million)
  - 4.8.2.2. Defibrillator Cardiac Leads Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  - 4.8.2.3. Average Selling Price Estimates & Forecast 2021 to 2033
  - 4.8.2.4. Traditional Leads
    - 4.8.2.4.1. Traditional Cardiac Leads Market Estimates and Forecasts 2021 To 2033 (USD Million)
    - 4.8.2.4.2. Traditional Cardiac Leads Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    - 4.8.2.4.3. Average Selling Price Estimates & Forecast 2021 to 2033
  - 4.8.2.5. LV Leads
    - 4.8.2.5.1. LV Cardiac Leads Market Estimates and Forecasts 2021 To 2033 (USD Million)
    - 4.8.2.5.2. LV Cardiac Leads Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    - 4.8.2.5.3. Average Selling Price Estimates & Forecast 2021 to 2033

Chapter 5. North America Cardiac Leads Market Segment Analysis, By End Use 2021 - 2033 (USD Million)

5.1. Definition and Scope
5.2. End Use Market Share Analysis, 2024 & 2033
5.3. Segment Dashboard
5.4. North America Cardiac Leads Market By End Use Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2021 To 2033, For the Following
- 5.5.1. Hospitals
  - 5.5.1.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
- 5.5.2. Ambulatory Surgery Centers
  - 5.5.2.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
- 5.5.3. Others
  - 5.5.3.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)

Chapter 6. North America Cardiac Leads Market Segment Analysis, By Country, 2021 - 2033 (Revenue in USD Million; Unit Volume in '000 Units; Average Selling Price [USD per Unit])

6.1. Country Market Share Analysis, 2024 & 2033
6.2. Country Market Dashboard
6.3. North America Country Market Snapshot
6.4. North America Cardiac Leads Market Share by Country, 2024 & 2033:
6.5. U.S.
- 6.5.1. Key Country Dynamics
- 6.5.2. Competitive Scenario
- 6.5.3. Regulatory Framework
- 6.5.4. U.S. Cardiac Leads Market, 2021 To 2033 (USD Million)
- 6.5.5. U.S. Cardiac Leads Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
- 6.5.6. Average Selling Price Estimates & Forecast 2021 to 2033
6.6. Canada
- 6.6.1. Key Country Dynamics
- 6.6.2. Competitive Scenario
- 6.6.3. Regulatory Framework
- 6.6.4. Canada Cardiac Leads Market, 2021 To 2033 (USD Million)
- 6.6.5. Canada Cardiac Leads Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
- 6.6.6. Average Selling Price Estimates & Forecast 2021 to 2033
6.7. Mexico
- 6.7.1. Key Country Dynamics
- 6.7.2. Competitive Scenario
- 6.7.3. Regulatory Framework
- 6.7.4. Mexico Cardiac Leads Market, 2021 To 2033 (USD Million)
- 6.7.5. Mexico Cardiac Leads Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
- 6.7.6. Average Selling Price Estimates & Forecast 2021 to 2033

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company Categorization (Key innovators, market leaders, emerging players)
7.3. Company Market Position Analysis, 2024
7.4. Company Market Share Analysis, 2024/2025 (%)
7.5. Company Profiles
- 7.5.1. Abbott
  - 7.5.1.1. Company overview
  - 7.5.1.2. Financial performance
  - 7.5.1.3. Product benchmarking
  - 7.5.1.4. Strategic initiatives
- 7.5.2. Medtronic
  - 7.5.2.1. Company overview
  - 7.5.2.2. Financial performance
  - 7.5.2.3. Product benchmarking
  - 7.5.2.4. Strategic initiatives
- 7.5.3. BOSTON SCIENTIFIC CORPORATION
  - 7.5.3.1. Company overview
  - 7.5.3.2. Financial performance
  - 7.5.3.3. Product benchmarking
  - 7.5.3.4. Strategic initiatives
- 7.5.4. Biotronik
  - 7.5.4.1. Company overview
  - 7.5.4.2. Financial performance
  - 7.5.4.3. Product benchmarking
  - 7.5.4.4. Strategic initiatives
- 7.5.5. Schiller
  - 7.5.5.1. Company overview
  - 7.5.5.2. Financial performance
  - 7.5.5.3. Product benchmarking
  - 7.5.5.4. Strategic initiatives
- 7.5.6. Koninklijke Philips N.V
  - 7.5.6.1. Company overview
  - 7.5.6.2. Financial performance
  - 7.5.6.3. Product benchmarking
  - 7.5.6.4. Strategic initiatives
- 7.5.7. MicroPort Scientific Corporation
  - 7.5.7.1. Company overview
  - 7.5.7.2. Financial performance
  - 7.5.7.3. Product benchmarking
  - 7.5.7.4. Strategic initiatives
- 7.5.8. Stryker
  - 7.5.8.1. Company overview
  - 7.5.8.2. Financial performance
  - 7.5.8.3. Product benchmarking
  - 7.5.8.4. Strategic initiatives
- 7.5.9. Lepu Medical Technology (Beijing) Co., Ltd.
  - 7.5.9.1. Company overview
  - 7.5.9.2. Financial performance
  - 7.5.9.3. Product benchmarking
  - 7.5.9.4. Strategic initiatives
- 7.5.10. MERIT MEDICAL SYSTEMS
  - 7.5.10.1. Company overview
  - 7.5.10.2. Financial performance
  - 7.5.10.3. Product benchmarking
  - 7.5.10.4. Strategic initiatives

Product Code: GVR-4-68040-819-5

List of Tables

Table 1 List Of Secondary Sources
Table 2 List Of Abbreviations
Table 3 North America Cardiac Leads Market, By Leads, 2021 - 2033 (USD Million)
Table 4 North America Cardiac Leads Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
Table 5 Average Selling Price Estimates & Forecast 2021 to 2033
Table 6 North America Cardiac Leads Market, By End Use, 2021 - 2033 (USD Million)
Table 7 U.S. Cardiac Leads Market, By Leads, 2021 - 2033 (USD Million)
Table 8 U.S. Cardiac Leads Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
Table 9 Average Selling Price Estimates & Forecast 2021 to 2033
Table 10 U.S. Cardiac Leads Market, By End Use, 2021 - 2033 (USD Million)
Table 11 Canada Cardiac Leads Market, By Leads, 2021 - 2033 (USD Million)
Table 12 Canada Cardiac Leads Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
Table 13 Average Selling Price Estimates & Forecast 2021 to 2033
Table 14 Canada Cardiac Leads Market, By End Use, 2021 - 2033 (USD Million)
Table 15 Mexico Cardiac Leads Market, By Leads, 2021 - 2033 (USD Million)
Table 16 Mexico Cardiac Leads Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
Table 17 Average Selling Price Estimates & Forecast 2021 to 2033
Table 18 Mexico Cardiac Leads Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Market Research Process
Fig. 2 Data Triangulation Techniques
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value-Chain-Based Sizing & Forecasting
Fig. 6 QFD Modeling For Market Share Assessment
Fig. 7 Market Formulation & Validation
Fig. 8 North America Cardiac Leads Market: Market Outlook
Fig. 9 North America Cardiac Leads Competitive Insights
Fig. 10 Parent Market Outlook
Fig. 11 Ancillary Market Outlook
Fig. 12 North America Cardiac Leads Market Driver Impact
Fig. 13 North America Cardiac Leads Market Restraint Impact
Fig. 14 Porter's Analysis
Fig. 15 PESTLE Analysis
Fig. 16 North America Cardiac Leads Market: Leads Movement Analysis
Fig. 17 North America Cardiac Leads Market: Leads Outlook and Key Takeaways
Fig. 18 Pacing Cardiac Leads Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in '000 Units; Average Selling Price [USD per Unit])
Fig. 19 Standard RV/LV Cardiac Leads Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in '000 Units; Average Selling Price [USD per Unit])
Fig. 20 Conduction System Pacing (CSP) / LBBAP Cardiac Leads Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in '000 Units; Average Selling Price [USD per Unit])
Fig. 21 Defibrillator Cardiac Leads Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in '000 Units; Average Selling Price [USD per Unit])
Fig. 22 Traditional Cardiac Leads Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in '000 Units; Average Selling Price [USD per Unit])
Fig. 23 LV Cardiac Leads Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in '000 Units; Average Selling Price [USD per Unit])
Fig. 24 North America Cardiac Leads Market: End Use Movement Analysis
Fig. 25 North America Cardiac Leads Market: End Use Outlook and Key Takeaways
Fig. 26 Hospitals Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 27 Ambulatory Surgery Centers Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 28 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 29 North America Cardiac Leads Market: Country Movement Analysis
Fig. 30 North America Cardiac Leads Market: Country Outlook and Key Takeaways
Fig. 31 North America Cardiac Leads Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in '000 Units; Average Selling Price [USD per Unit])
Fig. 32 Key Country Dynamics
Fig. 33 U.S. Cardiac Leads Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in '000 Units; Average Selling Price [USD per Unit])
Fig. 34 Key Country Dynamics
Fig. 35 Canada Cardiac Leads Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in '000 Units; Average Selling Price [USD per Unit])
Fig. 36 Key Country Dynamics
Fig. 37 Mexico Cardiac Leads Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in '000 Units; Average Selling Price [USD per Unit])
Fig. 38 Key company categorization
Fig. 39 Heat map analysis 2024

North America Cardiac Leads Market Size, Share & Trends Analysis Report By Leads (Pacing Leads, Defibrillator Leads), By End Use (Hospitals, Ambulatory Surgery Centers), By Country (U.S., Canada, Mexico), And Segment Forecasts, 2025 - 2033

Description

Table of Contents

List of Tables

North America Cardiac Leads Market Summary

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. North America Cardiac Leads Market: Executive Summary

Chapter 3. North America Cardiac Leads Market Variables, Trends, & Scope

Chapter 4. North America Cardiac Leads Market Segment Analysis, By Leads 2021 - 2033 (Revenue in USD Million; Unit Volume in '000 Units; Average Selling Price [USD per Unit])

Chapter 5. North America Cardiac Leads Market Segment Analysis, By End Use 2021 - 2033 (USD Million)

Chapter 6. North America Cardiac Leads Market Segment Analysis, By Country, 2021 - 2033 (Revenue in USD Million; Unit Volume in '000 Units; Average Selling Price [USD per Unit])

Chapter 7. Competitive Landscape

List of Tables

List of Figures